-
Sotatercept, sold
under the
brand name
Winrevair is a
medication used for the
treatment of
pulmonary arterial hypertension. It is an
activin signaling...
- and one in
preclinical development.
Luspatercept (ACE-536) for
anemia Sotatercept (ACE-011) for
pulmonary arterial hypertension Dalantercept (ACE-041)...
- test". Many have no data on
mortality benefit or time to progression.
Sotatercept (Winrevair) was
approved for
medical use in the
United States in March...
-
Radotermin Antagonists:
Inhibin (A, B)
Lefty (1, 2)
Decoy receptors:
Sotatercept ACVR2B Agonists:
Activin (A, B, AB) BMP (2, 4, 6, 7)
Dibotermin alfa...
-
would acquire Acceleron Pharma for $11.5 billion,
gaining control over
Sotatercept, used in the
treatment of
pulmonary hypertension, and luspatercept-aamt...
- Jurcic,
Joseph G; Sekeres,
Mikkael A; Berdeja, Jesus; et al. (2018). "
Sotatercept with long-term
extension for the
treatment of
anaemia in
patients with...
-
Radotermin Antagonists:
Inhibin (A, B)
Lefty (1, 2)
Decoy receptors:
Sotatercept ACVR2B Agonists:
Activin (A, B, AB) BMP (2, 4, 6, 7)
Dibotermin alfa...
-
Radotermin Antagonists:
Inhibin (A, B)
Lefty (1, 2)
Decoy receptors:
Sotatercept ACVR2B Agonists:
Activin (A, B, AB) BMP (2, 4, 6, 7)
Dibotermin alfa...
-
Radotermin Antagonists:
Inhibin (A, B)
Lefty (1, 2)
Decoy receptors:
Sotatercept ACVR2B Agonists:
Activin (A, B, AB) BMP (2, 4, 6, 7)
Dibotermin alfa...
-
Radotermin Antagonists:
Inhibin (A, B)
Lefty (1, 2)
Decoy receptors:
Sotatercept ACVR2B Agonists:
Activin (A, B, AB) BMP (2, 4, 6, 7)
Dibotermin alfa...
